| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Revenue | $637K | +128.3% |
| Cost of Revenue | $154K | — |
| R&D Expense | $4.2M | -33.9% |
| SG&A Expense | $8.9M | -0.9% |
| Operating Income | -$102.6M | -582.2% |
| Interest Expense | $248K | — |
| Pre-tax Income | -$67.3M | -669.1% |
| Income Tax | -$2.7M | -951.0% |
| Net Income | -$34.4M |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.7M | -87.6% |
| Accounts Receivable | $426K | +73.9% |
| Current Assets | $72.5M | -12.6% |
| Total Assets | $96.8M | -2.0% |
| Current Liabilities | $7.5M | +250.3% |
| Total Liabilities | $10.6M | +380.6% |
| Stockholders' Equity | $82.2M | -18.1% |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.8M | +28.3% |
| Capital Expenditures | $143K | — |
| Investing Cash Flow | -$10.8M | -151.0% |
| Financing Cash Flow | -$179K | +98.8% |
| Free Cash Flow | -$7.9M | — |
| -1734.2% |
| EPS (Basic) | -$1.45 | -1712.5% |
| EPS (Diluted) | -$1.45 | -1712.5% |